Trexquant Investment’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Trexquant Investment’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,925	Closed	-$847K	–	1894
2024 Q1	$847K	Buy	8,925 +5,810	+187%	+$539K	0.02%	977
2023 Q4	$278K	Buy	+3,115	New	+$231K	0.01%	1267
2023 Q3	–	Sell	-32,953	Closed	-$2.74M	–	1881
2023 Q2	$2.74M	Buy	32,953 +3,148	+11%	+$263K	0.07%	392
2023 Q1	$2.27M	Buy	+29,805	New	+$2.47M	0.06%	412
2022 Q2	–	Sell	-9,149	Closed	-$822K	–	1924
2022 Q1	$822K	Sell	9,149 -3,270	-26%	-$302K	0.04%	555
2021 Q4	$1.39M	Buy	+12,419	New	+$1.5M	0.09%	301
2021 Q1	–	Sell	-1,880	Closed	-$265K	–	1522
2020 Q4	$265K	Sell	1,880 -13,674	-88%	-$1.75M	0.03%	761
2020 Q3	$1.73M	Buy	15,554 +3,838	+33%	+$430K	0.11%	257
2020 Q2	$1.31M	Buy	+11,716	New	+$1.15M	0.09%	314

Other funds holding XBI

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Trexquant Investment's XBI Position: Q2 2024 in Review

Trexquant Investment sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 8,925 shares — an estimated $847K sold.

Trexquant Investment first reported a position in XBI in Q2 2020 and held it in 9 quarters. The position peaked at $2.74M in Q2 2023. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

Trexquant Investment reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
Trexquant Investment sold 8,925 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $847K.
Trexquant Investment first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 9 quarters.
Trexquant Investment's State Street SPDR S&P Biotech ETF position peaked at $2.74M in Q2 2023.
761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Trexquant Investment's 13F filing for Q2 2024, filed 13 Aug 2024.